APA

Coskun T., Sloop K. W., Loghin C., Alsina-Fernandez J., Urva S., Bokvist K. B., Cui X., Briere D. A., Cabrera O., Roell W. C., Kuchibhotla U., Moyers J. S., Benson C. T., Gimeno R. E., D'Alessio D. A. & Haupt A. (20190904). LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept. : Molecular metabolism.

Chicago

Coskun Tamer, Sloop Kyle W, Loghin Corina, Alsina-Fernandez Jorge, Urva Shweta, Bokvist Krister B, Cui Xuewei, Briere Daniel A, Cabrera Over, Roell William C, Kuchibhotla Uma, Moyers Julie S, Benson Charles T, Gimeno Ruth E, D'Alessio David A and Haupt Axel. 20190904. LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept. : Molecular metabolism.

Harvard

Coskun T., Sloop K. W., Loghin C., Alsina-Fernandez J., Urva S., Bokvist K. B., Cui X., Briere D. A., Cabrera O., Roell W. C., Kuchibhotla U., Moyers J. S., Benson C. T., Gimeno R. E., D'Alessio D. A. and Haupt A. (20190904). LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept. : Molecular metabolism.

MLA

Coskun Tamer, Sloop Kyle W, Loghin Corina, Alsina-Fernandez Jorge, Urva Shweta, Bokvist Krister B, Cui Xuewei, Briere Daniel A, Cabrera Over, Roell William C, Kuchibhotla Uma, Moyers Julie S, Benson Charles T, Gimeno Ruth E, D'Alessio David A and Haupt Axel. LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept. : Molecular metabolism. 20190904.